Phoniatric studies in myasthenia gravis patients [Phoniatrische untersuchungen an patienten mit myasthenia gravis]

被引:0
作者
Tóth L.
Pap U.
Diószeghy P.
Sziklai I.
机构
[1] HNO-Klinik (Direktor: Prof. Dr. I. Sziklai),
[2] Universität Debrecen,undefined
[3] Ungarn,undefined
[4] Neurologie-Klinik (Direktor: Prof. Dr. L. Csiba),undefined
[5] Universität Debrecen,undefined
[6] Ungarn,undefined
关键词
Myasthenia gravis; Phoniatrics; Voice profile;
D O I
10.1007/s001060050479
中图分类号
学科分类号
摘要
The authors have for the first time evaluated the basic parameters of the voice using computed voice analysis in patients with myasthenia gravis (MG). The aim of the study was to introduce an objective method suitable for the assessment of dysphonic symptoms, which predominate in bulbar, oculobulbar and generalized MG. Voice profile studies included the evaluation of the singing voice range, voice dynamics, maximum phonation time, and mean fundamental frequency and intensity, during speech. The characteristic of the stroboscopic picture was also determine. Investigations were carried out before and after the intake of Mestinon, a reversible cholinesterase inhibitor, and healthy subjects were used as a control group. In MG, the voice range and dynamics are badly impaired, maximum phonation time is shortened, the mean fundamental frequency during speech is increased, while the intensity is decreased. Mestinon resulted in an improvement in all these parameters, however, they were still impaired in comparison to the control subjects. Most changes were found to be statistically significant. The authors emphasize the role of the otolaryngologist and objective phoniatric methods in the evaluation of MG and other myasthenia-like neurological diseases. The use of these methods for the assessment of phoniatric symptoms in neurological diseases is highly recommended.
引用
收藏
页码:981 / 985
页数:4
相关论文
共 50 条
  • [1] Phoniatric studies in myasthenia gravis patients
    Tóth, L
    Pap, U
    Diószeghy, P
    Sziklai, I
    HNO, 1999, 47 (11) : 981 - 985
  • [2] Myasthenia Gravis
    Dahane, Arya
    Ambad, Ranjit S.
    Chakole, Swarupa
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2021, 14 (06): : 52 - +
  • [3] Myasthenia gravis
    Nicolle, MW
    NEUROLOGIST, 2002, 8 (01) : 2 - 21
  • [4] Myasthenia Gravis
    Gwathmey, Kelly G.
    Burns, Ted M.
    SEMINARS IN NEUROLOGY, 2015, 35 (04) : 327 - 339
  • [5] Myasthenia Gravis
    Drachman, Daniel B.
    SEMINARS IN NEUROLOGY, 2016, 36 (05) : 419 - 424
  • [6] Fatigue in patients with myasthenia gravis
    T. M. Alekseeva
    Y. V. Gavrilov
    O. A. Kreis
    P. O. Valko
    K. P. Weber
    Y. Valko
    Journal of Neurology, 2018, 265 : 2312 - 2321
  • [7] Fatigue in patients with myasthenia gravis
    Alekseeva, T. M.
    Gavrilov, Y. V.
    Kreis, O. A.
    Valko, P. O.
    Weber, K. P.
    Valko, Y.
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2312 - 2321
  • [8] Myasthenia gravis
    Spalek, Peter
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2008, 71 (01) : 7 - +
  • [9] Studies on new immunoadsorbent for Myasthenia Gravis
    Yan, WR
    Yu, YT
    Yang, L
    Zhang, WH
    Miao, PC
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2002, 23 (10): : 1887 - 1890
  • [10] Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis
    Vahabi, Zahra
    Nazari, Ferdos
    Fatehi, Farzad
    Bayegi, Valiolah
    Saffarian, Zahra
    Saffarian, Fatemeh
    Nafissi, Shahriar
    CURRENT JOURNAL OF NEUROLOGY, 2021, 20 (03):